Positive Effect of Lecithin-Based Delivery Form of Curcuma and Boswellia Extracts on Irritable Bowel Syndrome After COVID-19 Infection
Nutrients · 2025
DOI: 10.3390/nu17040723 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Attilio Giacosa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Italian Diagnostic Center (CDI), 20147 Milan, Italy. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Boswellia, Curcuma, Plant Extracts. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Post-COVID-19 irritable bowel syndrome (PCIBS) is a frequent finding and is frequently associated with enteral dysbiosis. This pilot study compared the effects of extracts from curcuma and boswellia on PCIBS and irritable bowel syndrome (IBS) in individuals who had never had a COVID-19 infection (controls).
Methods
A total of 16 subjects with PCIBS and 28 controls with evidence of IBS gastrointestinal symptoms and with enteral dysbiosis were recruited and supplemented for 30 days with sunflower-lecithin-based formulations of extracts of Curcuma longa (500 mg) and Boswellia serrata (150 mg) b.i.d. and with low-FODMAP diet. Abdominal bloating, abdominal pain, enteral dysbiosis (as increased urinary indican), and the global assessment of efficacy (GAE) were evaluated at the end of the study.
Results
In both cohorts, intra-cohort changes revealed a statistically significant (p < 0.05) reduction in bloating and abdominal pain. The GAE showed similar and relevant satisfactory rates in both groups. On the contrary, urinary indican values showed a significant decrease only in the IBS group.
Conclusions
Supplementation with Curcuma and Boswellia has favorable effects on abdominal bloating and abdominal pain of subjects with PCIBS and with IBS, while enteral dysbiosis is significantly decreased only in patients with IBS. Additional studies are needed to confirm these preliminary findings and to clarify the reasons for the persistence of dysbiosis in PCIBS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Italian Diagnostic Center (CDI), 20147 Milan, Italy.
- Endocrinology and Nutrition Unit, Azienda di Servizi Alla Persona "Istituto Santa Margherita", University of Pavia, 27100 Pavia, Italy.
- Department of Food, Environmental and Nutritional Sciences, Division of Human Nutrition, University of Milan, 20133 Milan, Italy.
- Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy.
ORCID-Profile: Gaetan Claude Barrile, Clara Gasparri, Simone Perna, Mariangela Rondanelli
Zitieren
APA
Giacosa, A., Barrile, G. C., Gasparri, C., Perna, S., & Rondanelli, M. (2025). Positive Effect of Lecithin-Based Delivery Form of Curcuma and Boswellia Extracts on Irritable Bowel Syndrome After COVID-19 Infection. Nutrients. https://doi.org/10.3390/nu17040723
Vancouver
Giacosa A, Barrile GC, Gasparri C, Perna S, Rondanelli M. Positive Effect of Lecithin-Based Delivery Form of Curcuma and Boswellia Extracts on Irritable Bowel Syndrome After COVID-19 Infection. Nutrients. 2025. doi:10.3390/nu17040723
BibTeX
@article{Giacosa2025,
author = {Giacosa, Attilio and Barrile, Gaetan Claude and Gasparri, Clara and Perna, Simone and Rondanelli, Mariangela},
title = {Positive Effect of Lecithin-Based Delivery Form of Curcuma and Boswellia Extracts on Irritable Bowel Syndrome After COVID-19 Infection},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17040723}
}
EUVIMED